Inogen reported $64.94M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 16.15B 1.66B Sep/2026
Accuray USD 199.44M 4.83M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 76.66M 30.28M Sep/2026
AtriCure USD 83.97M 2.06M Sep/2026
Baxter International USD 3.81B 218M Sep/2026
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Boston Scientific USD 5.98B 446M Sep/2026
Cooper Companies USD 1.87B 61.9M Jun/2026
Dexcom USD 2.25B 105.1M Sep/2026
Edwards Lifesciences USD 1.58B 68.8M Sep/2026
Globus Medical USD 507.94M 28.59M Sep/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 814.4M 70.2M Sep/2026
Medtronic USD 11.8B 141M Jun/2026
Orthofix International USD 138.38M 18.62M Sep/2026
Philips EUR 7.91B 485M Sep/2026
ResMed USD 1.32B 70.89M Sep/2026
Steris USD 1.21B 75.5M Sep/2026
Stryker USD 6.5B 184M Sep/2026
Tandem Diabetes Care USD 256.08M 3.07M Sep/2026
Teleflex USD 917.1M 196.72M Sep/2026
X T L Biopharmaceuticals USD 420K 341K Dec/2025
Zimmer Biomet Holdings USD 3.5B 488.9M Sep/2026